Abstract

BackgroundMild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD) and represents a risk factor for the development of dementia associated with PD (PDD). Since PDD has been associated with disability, caregiver burden, and an increase in health-related costs, early detection of MCI associated with PD (PD-MCI) and its biomarkers is crucial.ObjectiveGiven that gait is considered a surrogate marker for cognitive decline in PD, the aim of this study was to compare gait patterns in PD-MCI subtypes in order to verify the existence of an association between specific gait features and particular MCI subtypes.MethodsA total of 67 patients with PD were consecutively enrolled and assessed by an extensive clinical and cognitive examination. Based on the neuropsychological examination, patients were diagnosed as patients with MCI (PD-MCI) and without MCI (no-PD-MCI) and categorized in MCI subtypes. All patients were evaluated using a motion capture system of a BTS Bioengineering equipped with six IR digital cameras. Gait of the patients was assessed in the ON-state under three different tasks (a single task and two dual tasks). Statistical analysis included the t-test, the Kruskal–Wallis test with post hoc analysis, and the exploratory correlation analysis.ResultsGait pattern was poorer in PD-MCI vs. no-PD-MCI in all tasks. Among PD-MCI subtypes, multiple-domain PD-MCI and amnestic PD-MCI were coupled with worse gait patterns, notably in the dual task.ConclusionBoth the magnitude of cognitive impairment and the presence of memory dysfunction are associated with increased measures of dynamic unbalance, especially in dual-task conditions, likely mirroring the progressive involvement of posterior cortical networks.

Highlights

  • Cognitive decline is frequent in Parkinson’s disease (PD) even in the early stages, and it occurs as a dysfunction in executive, attention, memory, language, and visuospatial domains (Barone et al, 2011)

  • Thirty-two out of 67 patients were diagnosed as PD-Mild cognitive impairment (MCI) and 35 patients as no-PD-MCI

  • Patients with PD-MCI exhibited poorer gait patterns when compared with patients with no-PD-MCI

Read more

Summary

Introduction

Cognitive decline is frequent in Parkinson’s disease (PD) even in the early stages, and it occurs as a dysfunction in executive, attention, memory, language, and visuospatial domains (Barone et al, 2011). Since PDD has been associated with increased disability, caregiver burden, and risk for institutionalization with a consequent increase in healthrelated costs (Svenningsson et al, 2012), the early detection of MCI and its biomarkers is crucial for the identification of a PD subpopulation at a higher risk of worse disease progression (Mollenhauer et al, 2014). Mild cognitive impairment (MCI) is frequent in Parkinson’s disease (PD) and represents a risk factor for the development of dementia associated with PD (PDD). Since PDD has been associated with disability, caregiver burden, and an increase in health-related costs, early detection of MCI associated with PD (PD-MCI) and its biomarkers is crucial

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call